These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12377567)

  • 1. The importance of models of infection in the study of disease resistance.
    Druilhe P; Hagan P; Rook GA
    Trends Microbiol; 2002; 10(10 Suppl):S38-46. PubMed ID: 12377567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How reliable are models for malaria vaccine development? Lessons from irradiated sporozoite immunizations.
    Chatterjee S; Perignon JL; Van Marck E; Druilhe P
    J Postgrad Med; 2006; 52(4):321-4. PubMed ID: 17102561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High throughput genomic and proteomic technologies in the fight against infectious diseases.
    Tanca A; Deligios M; Addis MF; Uzzau S
    J Infect Dev Ctries; 2013 Mar; 7(3):182-90. PubMed ID: 23492995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The search for a tuberculosis vaccine: an elusive quest?
    Nagelkerke NJ; de Vlas SJ; Mahendradhata Y; Ottenhoff TH; Borgdorff M
    Tuberculosis (Edinb); 2006 Jan; 86(1):41-6. PubMed ID: 16253559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New approaches and omics tools for mining of vaccine candidates against vector-borne diseases.
    Kuleš J; Horvatić A; Guillemin N; Galan A; Mrljak V; Bhide M
    Mol Biosyst; 2016 Aug; 12(9):2680-94. PubMed ID: 27384976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines against dangerous pathogens.
    Williamson ED; Titball RW
    Br Med Bull; 2002; 62():163-73. PubMed ID: 12176858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogen genomics leading to vaccines.
    Nat Genet; 2019 Jun; 51(6):923. PubMed ID: 31152162
    [No Abstract]   [Full Text] [Related]  

  • 12. Innate immunity and new adjuvants.
    Mutwiri G; Gerdts V; Lopez M; Babiuk LA
    Rev Sci Tech; 2007 Apr; 26(1):147-56. PubMed ID: 17633299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines for Leprosy and Tuberculosis: Opportunities for Shared Research, Development, and Application.
    Coppola M; van den Eeden SJF; Robbins N; Wilson L; Franken KLMC; Adams LB; Gillis TP; Ottenhoff THM; Geluk A
    Front Immunol; 2018; 9():308. PubMed ID: 29535713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunology of tuberculosis: impact on the development of novel vaccines].
    Ulrichs T; Kaufmann SH
    Internist (Berl); 2003 Nov; 44(11):1374-84. PubMed ID: 14689073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combatting infectious diseases; nanotechnology as a platform for rational vaccine design.
    van Riet E; Ainai A; Suzuki T; Kersten G; Hasegawa H
    Adv Drug Deliv Rev; 2014 Jul; 74():28-34. PubMed ID: 24862579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of genomics on the analysis of host resistance to infectious disease.
    Tuite A; Gros P
    Microbes Infect; 2006 May; 8(6):1647-53. PubMed ID: 16697229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the progress of Mycobacterium tuberculosis H37Rv structural genomics.
    Fang Z; van der Merwe RG; Warren RM; Schubert WD; Gey van Pittius NC
    Tuberculosis (Edinb); 2015 Mar; 95(2):131-6. PubMed ID: 25578513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative 'omics analyses differentiate Mycobacterium tuberculosis and Mycobacterium bovis and reveal distinct macrophage responses to infection with the human and bovine tubercle bacilli.
    Malone KM; Rue-Albrecht K; Magee DA; Conlon K; Schubert OT; Nalpas NC; Browne JA; Smyth A; Gormley E; Aebersold R; MacHugh DE; Gordon SV
    Microb Genom; 2018 Mar; 4(3):. PubMed ID: 29557774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cells and antibodies in the defense against Mycobacterium tuberculosis infection.
    Achkar JM; Chan J; Casadevall A
    Immunol Rev; 2015 Mar; 264(1):167-81. PubMed ID: 25703559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling infectious disease - time to think outside the box?
    Wiles S; Hanage WP; Frankel G; Robertson B
    Nat Rev Microbiol; 2006 Apr; 4(4):307-12. PubMed ID: 16518420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.